Loading the company…
Loading the company…
ZimVie's former spine business, owned by H.I.G. Capital since April 2024. Families: Cervical fusion & disc arthroplasty, Lumbar fusion, Bone graft & orthobiologics.
All companies · Product and company coverage
The same products and surgeons under a new company (Highridge Medical): expect new reps and contracts, and ask what changed for them.
Payments and FDA records read by the company that owns the business today, so a deal never looks like surgeons switching; a surgeon’s payment history still shows the name each payment was made under.
In the last ten years FDA made 66 decisions for Highridge Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 3 procedure families, the most in 2017 (13). The latest was on 2026-09-16.
| Family | Decisions on record |
|---|---|
| Cervical fusion & disc arthroplasty | 118 |
| Lumbar fusion | 109 |
| Bone graft & orthobiologics | 10 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-09-16 | PMA | P110009-S040 | Mobi-C® Cervical Disc Prosthesis for use at Two Levels · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-09-16 | PMA | P110002-S040 | Mobi-C® Cervical Disc Prosthesis for use at One Level · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-03-23 | PMA | P110009-S038 | Mobi-C® P&F Cervical Disc Prosthesis · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-03-23 | PMA | P110002-S038 | Mobi-C® Cervical Disc Prosthesis · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-01-29 | PMA | P120024-S014 | activL Artificial Disc · Location Change - Manufacturer/Sterilizer/Packager/Supplier |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Highridge Medical.
In 2025, Highridge Medical reported engagement with 793 surgeons and other clinicians in the states MedaRep covers, worth $880K in consulting, speaking, meals and travel for its device products, the most in New York ($132K to 71). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: New York ($132K, 71 engaged), Illinois ($77K, 52 engaged), Utah ($75K, 11 engaged), Texas ($68K, 59 engaged), Virginia ($62K, 15 engaged).